Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Cerebral Hemorrhage

dabigatran has been researched along with Cerebral Hemorrhage in 68 studies

Research

Studies (68)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's62 (91.18)24.3611
2020's6 (8.82)2.80

Authors

AuthorsStudies
Del Zoppo, GJ; Gu, YH; Hawkins, BT; Izawa, Y; Koziol, JA; Yoshikawa, Y1
Cho, MS; Choi, KJ; Kang, DH; Kim, DH; Kim, J; Kim, M; Kim, SJ; Lee, S; Lee, SA; Nam, GB; Song, JM1
Arioli, D; Athanasiou, A; Ballestri, S; Capitelli, M; Cappi, C; Coluccio, V; Di Girolamo, M; Marietta, M; Marrazzo, A; Romagnoli, E1
Kuramatsu, JB; Sembill, JA1
Goyal, N; Mowla, A; Sadighi, A; Seiffge, DJ; Shahjouei, S; Tsivgoulis, G; Wang, M; Zand, R1
Moullaali, TJ; Parry-Jones, AR; Ziai, WC1
Barnes, GD; Cuker, A; Dawwas, GK; Dietrich, E; Leonard, CE; Lewis, JD1
Adachi, T; Fujioka, S; Hoshino, H; Takagi, M1
Gotoh, S; Kuwashiro, T; Nakamura, A; Nakanishi, Y; Okada, Y; Takaguchi, G; Tomoda, M; Yasaka, M1
Benavente, O; Butcher, K; Coutts, SB; Field, TS; Gioia, L; Hill, MD; Ng, KH; Sharma, M1
Alberts, MJ; Bunz, TJ; Coleman, CI; Peacock, WF1
Boulouis, G; Charidimou, A; Goldstein, JN; Gurol, ME; Morotti, A; Pasi, M1
Chaturvedi, S; Diener, HC; Hohnloser, SH; Molina, CA; Selim, MH1
Fuh, L; Goldstein, JN; Hayes, BD; Sin, JH1
Haas, K; Heuschmann, PU; Khan, S; Purrucker, JC; Rizos, T; Siedler, T; Veltkamp, R; Wolf, M1
Černík, D; Herzig, R; Jakubíček, S; Kunáš, Z; Mikulík, R; Ostrý, S; Reif, M; Rohan, V; Šaňák, D; Tomek, A; Veverka, T1
Bereczki, D; Kakuk, I; May, Z; Szakács, Z; Szilágyi, G1
Eichler, H; Hummel, BA; Schleicher, C; Senger, S1
Bakkehøi, G; Eek, AK; Stenberg-Nilsen, H; Strøm, BO1
Eto, A; Hiraoka, F; Nii, K; Tsutsumi, M1
Chen, CL; Chen, HM; Chen, LA; Chen, PL; Chou, PC; Fang, CW; Hsieh, CY; Li, YH; Lu, CM; Shih, YS; Sun, MC; Tsai, YT; Tsao, CR; Yeh, JT1
Bae, HJ; Chung, I; Gwak, DS; Han, MK; Kang, JH; Kim, BJ; Kim, BK; Woo, HG1
Arbel, M; Ayata, C; Bacskai, BJ; Böhm, M; Boulouis, G; Endres, M; Fischer, P; Frosch, MP; Greenberg, SM; Qin, T; Schlunk, F; Tamim, I1
Carrier, M; Ho, ML1
Ploen, R; Sun, L; Veltkamp, R; Zhou, W; Zorn, M1
Bauer, KA1
Dinkel, J; Foerch, C; Gupta, R; Hayakawa, K; Karatas, H; Lauer, A; Leung, W; Lo, EH; Schlunk, F; Steinmetz, H; Won, SY1
Damgaard, D; Simonsen, CZ; Steiner, T; Tietze, A1
Okada, Y; Yasaka, M2
Laroche, JP1
Hanon, O1
Faust, AC; Peterson, EJ1
Foerch, C; Lauer, A; Leung, W; Lo, EH; Lok, J; Schaefer, JH; Van Cott, EM; van Leyen, K; van Ryn, J; Whalen, M; Wu, L1
Hess, T; Konturek, P1
Berthold, C; Boecher-Schwarz, H; Dooms, G; Gunness, VR; Hana, A; Hertel, F; Koy, J; Matgé, G; Standhardt, H1
Ammollo, CT; Colucci, M; Semeraro, N; Testa, S; Visino, F; Zaccaria, F1
Hirose, Y; Inamasu, J; Tanoue, S; Toyama, H; Yamada, M1
Bernier-Jean, A; Bouchard, J; Eris, JM; Ghannoum, M; Kershaw, G; Patel, JP; Roberts, DM; Tran, H; Weatherburn, C; Williamson, D1
Bovi, P; Cappellari, M1
Mracsko, E; Na, SY; van Ryn, J; Veltkamp, R1
Collins, J; Fraeman, K; Reynolds, MW; Schnee, J; Schwartzman, E; Siu, K; Villines, TC1
Bartels, DB; Bykov, K; Huybrechts, K; Schneeweiss, S; Seeger, JD; Zint, K1
Yasaka, M1
Åsberg, S; Hijazi, Z; Norrving, B; Oldgren, J; Terent, A1
Einecke, D1
Pollack, CV1
Dittmeier, M; Fluri, F; Kleinschnitz, C; Kraft, P; Schuhmann, MK; Wassmuth, K1
Abe, H; Aizawa, Y; Fujii, Y; Jimbo, Y; Sato, M; Takahashi, H; Takano, H1
Abraham, NS; McBane, RD; Noseworthy, PA; Sangaralingham, LR; Shah, ND; Yao, X1
Biagi, C; Conti, V; Donati, M; Melis, M; Monaco, L; Motola, D; Vaccheri, A; Venegoni, M1
Clemens, A; Feuring, M; Haertter, S; Liesenfeld, KH; Stangier, J; van Ryn, J; Wienen, W1
Chan, L1
Michota, F1
Qureshi, AI; Siddiqui, FM; Watanabe, M1
Cianchetti, FA; Foerch, C; Lauer, A; Lo, EH; Pfeilschifter, W; Schaffer, CB; Schlunk, F; Schulz, E; Steinmetz, H; Van Cott, EM1
Bendszus, M; Heiland, S; Illanes, S; Liesz, A; Middelhoff, M; Schwarting, S; van Ryn, J; Veltkamp, R; Zhou, W; Zorn, M1
Calle Escobar, ML; Casado Naranjo, I; Jiménez Caballero, PE; Portilla-Cuenca, JC; Romero Sevilla, RM1
Dempfle, CE; Hennerici, MG1
Diener, HC; Eikelboom, J; Granger, CB; Hacke, W1
Baumgarten, P; Bohmann, F; Foerch, C; Lindhoff-Last, E; Mittelbronn, M; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H1
Brouns, R; De Keyser, J; De Raedt, S; De Smedt, A; Jochmans, K; Luijckx, GJ; Moens, M; Uyttenboogaart, M; Van Hooff, RJ1
Kowey, PR; Naccarelli, GV1
Fugate, JE; Lanzino, G; McBane, RD; Rabinstein, AA1
Diener, HC; Harenberg, J; Lip, GY; Marder, VJ; Marx, S; Wehling, M; Weiss, C1
Bohmann, F; Foerch, C; Lindhoff-Last, E; Mirceska, A; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H1
Gliem, M; Hartung, HP; Hermsen, D; Jander, S; van Rooijen, N1
Grove, EL; Husted, SE; Kraglund, KL; Modrau, B1

Reviews

18 review(s) available for dabigatran and Cerebral Hemorrhage

ArticleYear
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
    Advances in therapy, 2023, Volume: 40, Issue:1

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Stroke; Venous Thromboembolism

2023
[Acute treatment of intracerebral hemorrhage].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2019, Volume: 114, Issue:7

    Topics: Anticoagulants; Antihypertensive Agents; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Hematoma; Humans

2019
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
    Stroke, 2020, Volume: 51, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Middle Aged; Risk Factors; Stroke; Warfarin

2020
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
    Journal of neurology, neurosurgery, and psychiatry, 2018, Volume: 89, Issue:3

    Topics: Anticoagulants; Antithrombins; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Hematoma; Humans; Mortality; Odds Ratio; Phenprocoumon; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Thiazoles; Vitamin K; Warfarin

2018
Reversal of Oral Anticoagulants for Intracerebral Hemorrhage Patients: Best Strategies.
    Seminars in respiratory and critical care medicine, 2017, Volume: 38, Issue:6

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Humans; Vitamin K

2017
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
    Stroke, 2013, Volume: 44, Issue:6 Suppl 1

    Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Humans; Monitoring, Physiologic; Morpholines; Prodrugs; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Vitamin K; Warfarin

2013
[Novel oral anticoagulants and atrial fibrillation in the elderly].
    Geriatrie et psychologie neuropsychiatrie du vieillissement, 2013, Volume: 11, Issue:1 Suppl

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Drugs, Investigational; Half-Life; Humans; Intracranial Embolism; Metabolic Clearance Rate; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Vitamin K

2013
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
    MMW Fortschritte der Medizin, 2014, Feb-06, Volume: 156, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin

2014
NOAC and intracerebral bleeding--presentation of four cases and review of the literature.
    Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg, 2014, Issue:1

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Female; Humans; Hypertension; Male; Morpholines; Rivaroxaban; Thiophenes

2014
Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.
    Thrombosis and haemostasis, 2015, Volume: 114, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cerebral Hemorrhage; Contraindications; Dabigatran; Drug Administration Schedule; Drug Interactions; Endovascular Procedures; Factor Xa Inhibitors; Female; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Middle Aged; Practice Guidelines as Topic; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thrombectomy; Thrombolytic Therapy; Tissue Plasminogen Activator

2015
New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage.
    Frontiers of neurology and neuroscience, 2015, Volume: 37

    Topics: Animals; Anticoagulants; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Humans; Stroke

2015
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
    Thrombosis and haemostasis, 2010, Volume: 103, Issue:6

    Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation; Cerebral Hemorrhage; Charcoal; Dabigatran; Drug Overdose; Humans; International Normalized Ratio; Pyridines; Sensitivity and Specificity; Thrombin; Thrombin Time; Treatment Outcome; Venous Thromboembolism

2010
Intracerebral hemorrhage: Pick your poison.
    Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:11

    Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chronic Disease; Dabigatran; Humans; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Venous Thromboembolism; Warfarin

2010
Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.
    Neurocritical care, 2012, Volume: 16, Issue:1

    Topics: Benzimidazoles; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Humans; Incidence; Pyridines; Stroke; Thrombin

2012
Acute stroke management in patients taking dabigatran.
    CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:8

    Topics: Anticoagulants; Benzimidazoles; Blood Coagulation Disorders; Case Management; Cerebral Hemorrhage; Cerebral Infarction; Dabigatran; Guidelines as Topic; Hemostasis; Hemostatics; Humans; Off-Label Use; Pyridines; Renal Dialysis; Reperfusion; Stroke; Vitamin K

2012
Dabigatran: a primer for neurosurgeons.
    World neurosurgery, 2013, Volume: 79, Issue:1

    Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Humans; Neurosurgery; Perioperative Care; Postoperative Complications

2013
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    International angiology : a journal of the International Union of Angiology, 2012, Volume: 31, Issue:4

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chi-Square Distribution; Dabigatran; Embolism; Female; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Odds Ratio; Pyrazoles; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome

2012
[Anticoagulant therapy in stroke patients].
    Ugeskrift for laeger, 2013, Jan-28, Volume: 175, Issue:5

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Morpholines; Pyrazoles; Pyridones; Radiography; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thiophenes; Thromboembolism; Vitamin K

2013

Trials

2 trial(s) available for dabigatran and Cerebral Hemorrhage

ArticleYear
Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation.
    The American journal of cardiology, 2022, 07-15, Volume: 175

    Topics: Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Heart Valve Diseases; Humans; Stroke; Treatment Outcome; Warfarin

2022
Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II).
    International journal of stroke : official journal of the International Stroke Society, 2017, Volume: 12, Issue:8

    Topics: Administration, Oral; Antithrombins; Cerebral Hemorrhage; Dabigatran; Female; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Recurrence; Sample Size; Stroke; Treatment Outcome

2017

Other Studies

48 other study(ies) available for dabigatran and Cerebral Hemorrhage

ArticleYear
Intracerebral hemorrhage and thrombin-induced alterations in cerebral microvessel matrix.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022, Volume: 42, Issue:9

    Topics: Animals; Anticoagulants; Benzimidazoles; Cerebral Hemorrhage; Dabigatran; Mice; Microvessels; Thrombin

2022
Treatment of intracerebral hemorrhage: From specific interventions to bundles of care.
    International journal of stroke : official journal of the International Stroke Society, 2020, Volume: 15, Issue:9

    Topics: Administration, Oral; Anticoagulants; Cerebral Hemorrhage; Dabigatran; Hematoma; Humans; Stroke

2020
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
    Annals of internal medicine, 2021, Volume: 174, Issue:7

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Comparative Effectiveness Research; Dabigatran; Embolism; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Male; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Treatment Outcome; Warfarin

2021
Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Cerebrovascular diseases extra, 2017, Volume: 7, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Blood Coagulation; Cerebral Hemorrhage; Chi-Square Distribution; Cross-Sectional Studies; Dabigatran; Disability Evaluation; Factor Xa Inhibitors; Female; Hematoma; Humans; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Prospective Studies; Pyrazoles; Pyridones; Registries; Risk Factors; Rivaroxaban; Tomography, X-Ray Computed; Treatment Outcome; Warfarin

2017
[Measurement of Prothrombin Fragment 1+2 for the Assessment of Anticoagulant Activity in Patients Treated with Warfarin or Non-vitamin K Antagonist Oral Anticoagulant].
    Brain and nerve = Shinkei kenkyu no shinpo, 2017, Volume: 69, Issue:5

    Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Peptide Fragments; Prothrombin; Rivaroxaban; Warfarin

2017
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Stroke, 2017, Volume: 48, Issue:8

    Topics: Adolescent; Adult; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Cerebral Hemorrhage; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Warfarin; Young Adult

2017
Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.
    Stroke, 2017, Volume: 48, Issue:11

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Humans; Male; Off-Label Use; Stroke; Warfarin

2017
Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants.
    Acta neurologica Scandinavica, 2018, Volume: 138, Issue:2

    Topics: Aged; Aged, 80 and over; Anticoagulants; Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Comorbidity; Dabigatran; Female; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thrombolytic Therapy

2018
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:9

    Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Recombinant Proteins; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

2018
[Administration of idarucizumab in spontaneous intracerebral hemorrhage under dabigatran-therapy].
    Ideggyogyaszati szemle, 2017, Sep-30, Volume: 70, Issue:9-10

    Topics: Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Cerebral Hemorrhage; Dabigatran; Humans

2017
[The use of Idarucizumab in intracerebral bleeding - a case report].
    Deutsche medizinische Wochenschrift (1946), 2018, Volume: 113, Issue:13

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Atrial Fibrillation; Blood Coagulation Tests; Cerebral Hemorrhage; Dabigatran; Head Injuries, Closed; Hematoma, Subdural, Chronic; Humans; Male; Preoperative Care; Tomography, X-Ray Computed; Trephining

2018
Anticoagulant-associated adverse drug reactions in 2013-15.
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2018, 08-21, Volume: 138, Issue:12

    Topics: Age Distribution; Anticoagulants; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Registries; Risk Factors; Rivaroxaban; Sex Distribution; Time Factors; Warfarin

2018
[A Case of Successful Drug Management with Dabigatran and Idarucizumab to Address Embolic and Hemorrhagic Complications for Asymptomatic and Traumatic Subdural Hematoma with Non-valvular Atrial Fibrillation].
    No shinkei geka. Neurological surgery, 2018, Volume: 46, Issue:11

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Embolism; Female; Hematoma, Subdural; Humans

2018
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:3

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Drug Administration Schedule; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Risk Factors; Stroke; Taiwan; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome

2019
Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2019, Volume: 61

    Topics: Administration, Oral; Aged; Anticoagulants; Asian People; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Middle Aged; Odds Ratio; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Warfarin; Young Adult

2019
Secondary Bleeding During Acute Experimental Intracerebral Hemorrhage.
    Stroke, 2019, Volume: 50, Issue:5

    Topics: Acute Disease; Animals; Anticoagulants; Cerebral Hemorrhage; Dabigatran; Hemorrhage; Male; Mice; Random Allocation; Warfarin

2019
Just the facts: Management of life-threatening bleeding with oral anticoagulant use in the emergency department.
    CJEM, 2019, Volume: 21, Issue:4

    Topics: Administration, Oral; Algorithms; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Cerebral Hemorrhage; Checklist; Clinical Decision-Making; Dabigatran; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Middle Aged; Tranexamic Acid

2019
Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
    Thrombosis and haemostasis, 2013, Volume: 110, Issue:1

    Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood-Brain Barrier; Cerebral Arteries; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Humans; Ischemia; Mice; Mice, Inbred C57BL; Rats; Stroke; Thrombolytic Therapy; Warfarin

2013
Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
    Stroke, 2013, Volume: 44, Issue:10

    Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Contrast Media; Dabigatran; Iopamidol; Male; Mice; Radiography, Dual-Energy Scanned Projection; Time Factors; Warfarin

2013
Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:2

    Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Fatal Outcome; Hematoma; Humans; Male; Risk Factors; Stroke; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2014
[Prevention and treatment of major bleeding during anticoagulation].
    Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:11

    Topics: Administration, Oral; Alcohol Drinking; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Diabetes Mellitus; Drug Therapy, Combination; Factor IX; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Risk Assessment; Risk Factors; Smoking; Vitamin K; Warfarin

2013
[New anticoagulants: stop or more?].
    Journal des maladies vasculaires, 2014, Volume: 39, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Anticoagulants; Antidotes; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Dissent and Disputes; Dose-Response Relationship, Drug; Drug Approval; Drug Industry; Drugs, Investigational; France; Humans; International Normalized Ratio; Lobbying; Pharmacovigilance; Thrombophilia

2014
Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
    The Journal of emergency medicine, 2014, Volume: 46, Issue:4

    Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Humans; Male

2014
Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014, Volume: 34, Issue:5

    Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Factors; Brain; Brain Injuries; Cerebral Hemorrhage; Dabigatran; Hemorrhage; Mice; Mice, Inbred C57BL; Warfarin

2014
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding.
    British journal of haematology, 2015, Volume: 168, Issue:6

    Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Case-Control Studies; Cerebral Hemorrhage; Dabigatran; Humans; Thromboplastin; Warfarin

2015
Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage?
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2015, Volume: 24, Issue:2

    Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Collagenases; Dabigatran; Disease Models, Animal; Hematoma; Male; Rats; Rats, Wistar; Time Factors

2015
Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
    Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:3

    Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Cerebral Hemorrhage; Dabigatran; Drug Monitoring; Fatal Outcome; Female; Half-Life; Hemorrhage; Humans; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Replacement Therapy; Time Factors; Treatment Outcome

2015
Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.
    Annals of neurology, 2015, Volume: 78, Issue:1

    Topics: Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Bleeding Time; Blood Coagulation; Brain; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Hematoma; Mice; Thrombin Time; Warfarin

2015
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Disease-Free Survival; Drug Evaluation; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Insurance Coverage; Kaplan-Meier Estimate; Male; Middle Aged; Military Personnel; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult

2015
Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation.
    Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Drug Evaluation; Embolism; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Insurance Coverage; Male; Middle Aged; Myocardial Infarction; Polypharmacy; Propensity Score; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult

2015
[Anticoagulants after acute ischemic stroke with atrial fibrillation].
    Lakartidningen, 2016, 03-01, Volume: 113

    Topics: Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Deglutition Disorders; Humans; Medical Records; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Rivaroxaban; Stroke; Time Factors; Time-to-Treatment; Treatment Outcome; Warfarin

2016
[First new oral anticoagulant with specific antidote].
    MMW Fortschritte der Medizin, 2016, Mar-17, Volume: 158, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Cerebral Hemorrhage; Dabigatran; Humans; Infusions, Intravenous; Stroke

2016
Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
    Circulation, 2016, Jan-12, Volume: 133, Issue:2

    Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Loss, Surgical; Cerebral Hemorrhage; Clinical Trials as Topic; Dabigatran; Drug Approval; Emergencies; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiazoles; United States; United States Food and Drug Administration

2016
Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke.
    Current neurovascular research, 2016, Volume: 13, Issue:3

    Topics: Animals; Anticoagulants; Blood Coagulation; Blood-Brain Barrier; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Inflammation; Male; Rats, Wistar; Stroke; Thrombin; Thrombosis

2016
Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    The American journal of cardiology, 2016, Jul-15, Volume: 118, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Brain; Case-Control Studies; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Female; Hematoma; Hospital Mortality; Humans; Male; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Tomography, X-Ray Computed; Warfarin

2016
Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation.
    Chest, 2016, Volume: 150, Issue:6

    Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; United States

2016
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Child; Child, Preschool; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Warfarin; World Health Organization; Young Adult

2017
Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?
    Archives of neurology, 2010, Volume: 67, Issue:9

    Topics: Benzimidazoles; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Humans; Pyridines; Stroke; Tissue Plasminogen Activator

2010
Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.
    Circulation, 2011, Oct-11, Volume: 124, Issue:15

    Topics: Administration, Oral; Animals; Anticoagulants; Antithrombin Proteins; Benzimidazoles; Cerebral Hemorrhage; Collagenases; Dabigatran; Hematoma; Injections; Male; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; Partial Thromboplastin Time; Pyridines; Time Factors; Warfarin

2011
Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.
    Stroke, 2011, Volume: 42, Issue:12

    Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Brain; Cerebral Hemorrhage; Dabigatran; Dose-Response Relationship, Drug; Mice

2011
Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
    Cerebrovascular diseases (Basel, Switzerland), 2011, Volume: 32, Issue:6

    Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Cerebrovascular Circulation; Dabigatran; Electric Countershock; Fatal Outcome; Fibrinolytic Agents; Humans; Male; Middle Aged; Stroke; Tissue Plasminogen Activator; Tomography, X-Ray Computed

2011
Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
    Cerebrovascular diseases (Basel, Switzerland), 2011, Volume: 32, Issue:6

    Topics: Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Fibrinolytic Agents; Humans; Male; Stroke; Tissue Plasminogen Activator

2011
The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
    International journal of stroke : official journal of the International Stroke Society, 2012, Volume: 7, Issue:2

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Thrombin; Warfarin

2012
Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Annals of neurology, 2012, Volume: 71, Issue:5

    Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Drug Interactions; Fibrinolytic Agents; Mice; Mice, Inbred C57BL; Stroke; Tissue Plasminogen Activator; Warfarin

2012
The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out.
    The American journal of medicine, 2012, Volume: 125, Issue:8

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Humans; Risk Assessment; Stroke; Thrombin; United States; United States Food and Drug Administration

2012
No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Administration, Oral; Animals; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Male; Mice; Pyridines; Stroke; Treatment Outcome

2012
Secondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in mice.
    Stroke, 2012, Volume: 43, Issue:12

    Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Blood Coagulation; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Intracranial Embolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Phenprocoumon; Pyridines; Risk Factors; Stroke; Time Factors

2012
[Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants].
    Rinsho shinkeigaku = Clinical neurology, 2012, Volume: 52, Issue:11

    Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Humans; Intracranial Embolism; Morpholines; Rivaroxaban; Thiophenes; Warfarin

2012